Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
M. V. Maevskaya, Yu. V. Kotovskaya, В. Т. Ивашкин, et al.
Terapevticheskii arkhiv (2022) Vol. 94, Iss. 2, pp. 216-253
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Nonalcoholic fatty liver disease and chronic kidney disease: random connections or two manifestations of metabolic syndrome?
Н. С. Карпунина, О. В. Хлынова
Experimental and Clinical Gastroenterology (2025), Iss. 8, pp. 123-130
Closed Access
Clinical and genetic features of toxic liver damage in workers of petrochemical enterprises
Eldar R. Kudoyarov, Dinara P. Ivanova, А Б Бакиров, et al.
Russian Journal of Occupational Health and Industrial Ecology (2025) Vol. 65, Iss. 1, pp. 49-56
Closed Access
ОЖИРЕНИЕ И НЕАЛКОГОЛЬНЫЙ ЖИРОВЫЙ ГЕПАТОЗ ПЕЧЕНИ ПЕРСОНАЛИЗИРОВАННЫЙ ПОДХОД К КОРРЕКЦИИ
Дилафруз Тураева, Лиля Гарифулина
Международный журнал научной педиатрии (2025) Vol. 4, Iss. 1, pp. 855-860
Closed Access
Metabolic dysfunction associated steatotic liver disease in lean patients. Diagnostic and treatment challenges
E. E. Zabotina, Yu. A. Khabarova, N. Yu. Stukova
Experimental and Clinical Gastroenterology (2025), Iss. 9, pp. 96-109
Closed Access
Non-Alcoholic Fatty Liver Disease and Bone Tissue Metabolism: Current Findings and Future Perspectives
Oxana M. Drapkina, Anastasia Yu. Elkina, А.Ф. Шептулина, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8445-8445
Open Access | Times Cited: 14
Prevalence of non-alcoholic fatty liver disease among the working-age population: associations with socio-demographic indicators and behavioral risk factors (ESSE RF-2 data)
С. Е. Евстифеева, S. А. Shalnova, В. А. Куценко, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2022) Vol. 21, Iss. 9, pp. 3356-3356
Open Access | Times Cited: 17
Liver fibrosis in nonalcoholic fatty liver disease: the role of adipokines and noninvasive assessment of the intestinal barrier
Т. С. Кролевец, М. А. Ливзан, M.I. Syrovenko
Russian Journal of Evidence-Based Gastroenterology (2023) Vol. 12, Iss. 2, pp. 46-46
Closed Access | Times Cited: 6
Efficacy of human placenta hydrolyzate in the treatment of patients with metabolic associated fatty liver disease at the stage of fibrosis (pilot study)
E. V. Vinnitskaya, Yu.G. Sandler, K. G. Saliev, et al.
Terapevticheskii arkhiv (2024) Vol. 96, Iss. 2, pp. 107-116
Closed Access | Times Cited: 1
A method of diagnosing non-alcoholic fatty liver disease with the calculation of the steatosis index
И. А. Булатова, A. A. Sobol, I. L. Gulyaeva
Perm Medical Journal (2024) Vol. 41, Iss. 1, pp. 108-113
Open Access
Functional state of the liver and endothelium in patients with menopausal metabolic syndrome
И. А. Булатова, Tatyana P. Shevlyukova, I. L. Gulyaeva, et al.
GYNECOLOGY (2024) Vol. 26, Iss. 2, pp. 185-190
Closed Access
Lactitol properties in the treatment of patients with lifestyle-related diseases
M. V. Maevskaya, С. В. Оковитый
Meditsinskiy sovet = Medical Council (2024), Iss. 8, pp. 162-169
Open Access
The role of short-chain fatty acids in the progression of non-alcoholic fatty liver disease
Т. С. Кролевец, М. А. Ливзан, M.I. Syrovenko
Meditsinskiy sovet = Medical Council (2024), Iss. 8, pp. 50-58
Open Access
NAFLD is a predictor of high risk of development and a co-factor in the progression of cardiovascular diseases
Г. В. Шавкута, С. В. Туркина
South Russian Journal of Therapeutic Practice (2024) Vol. 5, Iss. 2, pp. 29-37
Open Access
Prediction model for the development of liver fibrosis in patients with metabolic dysfunction–associated steatotic liver disease
T.S. Krolevets, М. А. Ливзан, M.I. Syrovenko, et al.
Russian Medical Inquiry (2024) Vol. 8, Iss. 5
Open Access
Non-Coding RNAs Involved in the Regulation of Signaling Pathways as Possible Markers of Non-Alcoholic Fatty Liver Disease Progression
Л. В. Топчиева, И. В. Курбатова, О. П. Дуданова, et al.
Biology Bulletin (2024) Vol. 51, Iss. 5, pp. 1271-1290
Closed Access
Liver Fibrosis in Some Patients with Non-Alcoholic Fatty Liver Disease: from Diagnosis to Prognosis
Т. С. Кролевец, М. А. Ливзан, M.I. Syrovenko
Annals of the Russian academy of medical sciences (2024) Vol. 79, Iss. 4, pp. 293-300
Closed Access
Metabolic dysfunction-associated steatotic liver disease and drug-induced injuries: Pathogenetic aspects, treatment and prevention
И. Г. Пахомова
Meditsinskiy sovet = Medical Council (2024), Iss. 15, pp. 70-78
Open Access
The possibilities of using ursodeoxycholic acid in the practice of a gastroenterologist and therapist
G.Yu. Knorring, Yu. V. Sedyakina, S. S. Kurdzhieva
Medical alphabet (2024), Iss. 26, pp. 28-32
Closed Access
Role of MMP-2 and MMP-9 in the Relationship between Inflammation, Fibrosis, and Apoptosis during Progression of Non-Alcoholic Fatty Liver Disease and Diagnostic Significance of Plasma Levels of Their Active Forms
И. В. Курбатова, Lyudmila Topchieva, О. П. Дуданова, et al.
Biochemistry (Moscow) (2024) Vol. 89, Iss. 11, pp. 1998-2022
Closed Access
Non-coding RNAs involved in the regulation of signaling pathways as possible markers of non-alcoholic fatty liver disease progression
Lyudmila Topchieva, G. A. Zhulay, И. В. Курбатова, et al.
Известия Российской академии наук Серия биологическая (2024), Iss. 5
Closed Access
Non-alcoholic fatty liver disease and cognitive impairment
Е. В. Онучина, Bairma B. Dambaeva, Александра Михайловна Глазунова, et al.
Terapevticheskii arkhiv (2024) Vol. 96, Iss. 12, pp. 1198-1205
Open Access
Type 2 diabetes mellitus, non-alcoholic fatty liver disease and cardiovascular disease: causal relationships and the role of anti-diabetic drugs
T. Yu. Demidova, Д. В. Скуридина, E. S. Pervushina
FOCUS Endocrinology (2023) Vol. 4, Iss. 1, pp. 6-15
Open Access | Times Cited: 1
Metabolic-associated fatty liver disease (NAFLD) as a cancer risk factor
Т. С. Кролевец, М. А. Ливзан
Experimental and Clinical Gastroenterology (2023), Iss. 3, pp. 120-127
Open Access | Times Cited: 1
Non-alcoholic fatty liver disease and the risk of malignant tumors
М. А. Ливзан, M.I. Syrovenko, Т. С. Кролевец
Meditsinskiy sovet = Medical Council (2023), Iss. 18, pp. 75-82
Open Access | Times Cited: 1
Lifestyle of patients with non-alcoholic fatty liver disease: assessment of dietary habits and physical activity
Т. С. Кролевец, M.I. Syrovenko, М. А. Ливзан
Russian Journal of Evidence-Based Gastroenterology (2023) Vol. 12, Iss. 4, pp. 43-43
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top